HK1139076A1 - Lyophilized preparation comprising influenza vaccine, and method for preparation thereof - Google Patents
Lyophilized preparation comprising influenza vaccine, and method for preparation thereofInfo
- Publication number
- HK1139076A1 HK1139076A1 HK10105830.1A HK10105830A HK1139076A1 HK 1139076 A1 HK1139076 A1 HK 1139076A1 HK 10105830 A HK10105830 A HK 10105830A HK 1139076 A1 HK1139076 A1 HK 1139076A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- influenza vaccine
- preparation
- freeze
- iii
- dried preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16051—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Pulmonology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007059724 | 2007-03-09 | ||
PCT/JP2008/054210 WO2008111532A1 (ja) | 2007-03-09 | 2008-03-07 | インフルエンザワクチン含有凍結乾燥製剤、及びその製造方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1139076A1 true HK1139076A1 (en) | 2010-09-10 |
Family
ID=39759470
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10105830.1A HK1139076A1 (en) | 2007-03-09 | 2010-06-10 | Lyophilized preparation comprising influenza vaccine, and method for preparation thereof |
Country Status (20)
Country | Link |
---|---|
US (1) | US8216588B2 (pt) |
EP (1) | EP2119451A4 (pt) |
JP (1) | JP5388842B2 (pt) |
KR (1) | KR20090128463A (pt) |
CN (1) | CN101631563B (pt) |
AR (1) | AR065640A1 (pt) |
AU (1) | AU2008225501B2 (pt) |
BR (1) | BRPI0808037A2 (pt) |
CA (1) | CA2680193C (pt) |
HK (1) | HK1139076A1 (pt) |
IL (1) | IL200588A0 (pt) |
MX (1) | MX2009009635A (pt) |
MY (1) | MY149924A (pt) |
NZ (1) | NZ579395A (pt) |
RU (1) | RU2484847C2 (pt) |
SG (1) | SG179406A1 (pt) |
TW (1) | TWI428140B (pt) |
UA (1) | UA97391C2 (pt) |
WO (1) | WO2008111532A1 (pt) |
ZA (1) | ZA200905952B (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0614460D0 (en) * | 2006-07-20 | 2006-08-30 | Novartis Ag | Vaccines |
CN108588035A (zh) * | 2011-06-28 | 2018-09-28 | 白血球保健股份有限公司 | 病毒或细菌的新型稳定方法 |
WO2014117056A1 (en) * | 2013-01-25 | 2014-07-31 | Wintermute Biomedical, Llc | Therapeutic compounds |
GB201314248D0 (en) * | 2013-08-08 | 2013-09-25 | Glaxosmithkline Biolog Sa | Saccharide vaccine formulation |
CA2923010C (en) * | 2013-09-03 | 2022-08-30 | Georgia Tech Research Corporation | Thermally stable vaccine formulations and microneedles |
US10588957B2 (en) * | 2013-10-25 | 2020-03-17 | Leukocare Ag | Method for the production of stabile vaccines |
WO2017090767A1 (ja) * | 2015-11-27 | 2017-06-01 | 日東電工株式会社 | インフルエンザワクチン乾燥製剤、及び、インフルエンザワクチン乾燥製剤の製造方法 |
EP3381467A4 (en) | 2015-11-27 | 2019-06-05 | Nitto Denko Corporation | PHARMACEUTICAL VACCINE COMPOSITION FOR ORAL ADMINISTRATION AND METHOD FOR PREPARING A PHARMACEUTICAL VACCINE COMPOSITION FOR ORAL ADMINISTRATION |
TW201720426A (zh) | 2015-11-27 | 2017-06-16 | Nitto Denko Corp | 流感疫苗乾燥製劑、及流感疫苗乾燥製劑之製造方法 |
US11065220B2 (en) | 2017-02-13 | 2021-07-20 | Wintermute Biomedical, Inc. | Anti-pathogenic therapeutic compositions |
CA3115050A1 (en) | 2018-10-01 | 2020-04-09 | Wintermute Biomedical, Inc. | Therapeutic compositions |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2505657A1 (fr) * | 1981-05-13 | 1982-11-19 | Pasteur Institut | Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation |
US4537769A (en) * | 1982-04-06 | 1985-08-27 | American Cyanamid Company | Stabilization of influenza virus vaccine |
JPH07121871B2 (ja) * | 1986-10-09 | 1995-12-25 | 国立予防衛生研究所長 | インフルエンザワクチン凍結乾燥製剤 |
JPH05229960A (ja) * | 1990-10-30 | 1993-09-07 | Dai Ichi Seiyaku Co Ltd | 新規インフルエンザワクチン |
JPH0813753B2 (ja) * | 1992-05-22 | 1996-02-14 | 株式会社微生物化学研究所 | 牛伝染性鼻気管炎ウイルス感染症、牛ウイルス性下痢−粘膜病ウイルス感染症、パラインフルエンザ3型ウイルス感染症、牛rsウイルス感染症および牛アデノ7型ウイルス感染症5種混合生ワクチン |
CA2403962C (en) * | 2000-03-31 | 2009-12-15 | Kirin Beer Kabushiki Kaisha | Powdery preparation for transmucosal administration comprising a medicine of high molecular weight and exhibiting an improved storage stability |
EG24184A (en) * | 2001-06-15 | 2008-10-08 | Otsuka Pharma Co Ltd | Dry powder inhalation system for transpulmonary |
JP2004054555A (ja) * | 2002-07-19 | 2004-02-19 | Yokogawa Electric Corp | 表示装置 |
EP1597400B8 (en) * | 2003-02-25 | 2013-10-09 | MedImmune, LLC | Methods of producing influenza vaccine compositions |
CN101060859B (zh) * | 2004-10-06 | 2011-11-09 | 米迪缪尼有限公司 | 冷藏温度稳定的流感疫苗组合物 |
RU2290205C1 (ru) * | 2005-09-13 | 2006-12-27 | Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунологическим препаратам "МИКРОГЕН" Министерства здравоохранения Российской Федерации | Способ получения живой вакцины для профилактики гриппа |
-
2008
- 2008-03-07 RU RU2009137380/15A patent/RU2484847C2/ru not_active IP Right Cessation
- 2008-03-07 CN CN2008800077114A patent/CN101631563B/zh not_active Expired - Fee Related
- 2008-03-07 EP EP08721627A patent/EP2119451A4/en not_active Withdrawn
- 2008-03-07 CA CA2680193A patent/CA2680193C/en not_active Expired - Fee Related
- 2008-03-07 MX MX2009009635A patent/MX2009009635A/es active IP Right Grant
- 2008-03-07 AU AU2008225501A patent/AU2008225501B2/en not_active Ceased
- 2008-03-07 SG SG2012012985A patent/SG179406A1/en unknown
- 2008-03-07 UA UAA200910179A patent/UA97391C2/ru unknown
- 2008-03-07 MY MYPI20093554A patent/MY149924A/en unknown
- 2008-03-07 BR BRPI0808037-2A2A patent/BRPI0808037A2/pt not_active IP Right Cessation
- 2008-03-07 US US12/529,893 patent/US8216588B2/en not_active Expired - Fee Related
- 2008-03-07 WO PCT/JP2008/054210 patent/WO2008111532A1/ja active Application Filing
- 2008-03-07 KR KR1020097020993A patent/KR20090128463A/ko active IP Right Grant
- 2008-03-07 AR ARP080100948A patent/AR065640A1/es unknown
- 2008-03-07 JP JP2009504039A patent/JP5388842B2/ja not_active Expired - Fee Related
- 2008-03-07 NZ NZ579395A patent/NZ579395A/en not_active IP Right Cessation
- 2008-03-07 TW TW097108118A patent/TWI428140B/zh not_active IP Right Cessation
-
2009
- 2009-08-26 IL IL200588A patent/IL200588A0/en unknown
- 2009-08-27 ZA ZA2009/05952A patent/ZA200905952B/en unknown
-
2010
- 2010-06-10 HK HK10105830.1A patent/HK1139076A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
UA97391C2 (ru) | 2012-02-10 |
ZA200905952B (en) | 2010-11-24 |
RU2484847C2 (ru) | 2013-06-20 |
MY149924A (en) | 2013-10-31 |
TW200848074A (en) | 2008-12-16 |
AU2008225501B2 (en) | 2013-08-29 |
KR20090128463A (ko) | 2009-12-15 |
JPWO2008111532A1 (ja) | 2010-06-24 |
NZ579395A (en) | 2012-05-25 |
BRPI0808037A2 (pt) | 2014-06-17 |
EP2119451A4 (en) | 2012-05-16 |
US8216588B2 (en) | 2012-07-10 |
CN101631563A (zh) | 2010-01-20 |
JP5388842B2 (ja) | 2014-01-15 |
SG179406A1 (en) | 2012-04-27 |
TWI428140B (zh) | 2014-03-01 |
CN101631563B (zh) | 2013-07-24 |
MX2009009635A (es) | 2009-09-22 |
AU2008225501A2 (en) | 2009-09-24 |
US20100104595A1 (en) | 2010-04-29 |
AU2008225501A1 (en) | 2008-09-18 |
WO2008111532A1 (ja) | 2008-09-18 |
AR065640A1 (es) | 2009-06-17 |
EP2119451A1 (en) | 2009-11-18 |
RU2009137380A (ru) | 2011-04-20 |
CA2680193A1 (en) | 2008-09-18 |
IL200588A0 (en) | 2010-05-17 |
CA2680193C (en) | 2015-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1139076A1 (en) | Lyophilized preparation comprising influenza vaccine, and method for preparation thereof | |
WO2010149743A3 (en) | Vaccine | |
WO2007035455A3 (en) | Stabilizers for freeze-dried vaccines | |
CA2746228C (en) | Modified rsv f proteins and methods of their use | |
EP4349405A3 (en) | Respiratory virus vaccines | |
WO2010146598A3 (en) | Stable, dried rotavirus vaccine, compositions and process for preparation thereof | |
CA2817005A1 (en) | Rabies glycoprotein virus-like particles (vlps) | |
JP2017533218A5 (pt) | ||
WO2007048086A3 (en) | Canine influenza virus and related compositions and methods of use | |
PL2443202T3 (pl) | Wodna zawiesina aktywowanego powierzchniowo węglanu wapnia, otrzymane produkty i ich zastosowania | |
PE20100035A1 (es) | Proteina de cereal hidrolizado parcialmente | |
NZ600891A (en) | Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs | |
MY184277A (en) | Formulations of deoxyccholic acid and salts thereof | |
WO2009118754A3 (en) | A process for preparing a stable lyophilized composition | |
MX2013005953A (es) | Astringencia en soluciones de proteina de soya. | |
WO2012054907A3 (en) | Novel hemagglutinin 5 (h5) proteins for the treatment and prevention of influenza infections | |
MX349837B (es) | Composicion de transglutaminasa seca. | |
WO2011051916A3 (en) | Stabilized protein formulations and use thereof | |
NZ613554A (en) | Caprylate viral deactivation | |
UA110933C2 (uk) | Композиція для лікування есенціальної тромбоцитемії | |
ATE415151T1 (de) | Formulierung zur verzögerten freisetzung von valproinsäure und deren derivate | |
TH108771A (th) | สารปรุงสำเร็จที่แห้งแบบเยือกแข็งที่มีวัคซีนไข้หวัดใหญ่ และวิธีสำหรับผลิตสารดังกล่าว | |
MX2015009141A (es) | Formulaciones de albu-bche, preparacion y usos de las mismas. | |
TH108771B (th) | สารปรุงสำเร็จที่แห้งแบบเยือกแข็งที่มีวัคซีนไข้หวัดใหญ่ และวิธีสำหรับผลิตสารดังกล่าว | |
WO2010095978A3 (ru) | Способ получения препарата проинсулина для перорального применения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20170307 |